FC
AVNS icon

Financial Consulate’s Avanos Medical AVNS Stock Holding History

Financial Consulate’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$505 Hold
36
– – ﹤0.01% 1262
2025
Q4 		$405 Hold
36
– – ﹤0.01% 1238
2025
Q3 		$417 Buy
+36
New +$422 ﹤0.01% 1089

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Financial Consulate's AVNS Position: Q1 2026 in Review

Financial Consulate held its Avanos Medical (AVNS) position steady in Q1 2026 at 36 shares worth $505. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Financial Consulate first reported a position in AVNS in Q3 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Financial Consulate held 36 shares of Avanos Medical worth $505 as of Q1 2026.
  • Financial Consulate left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #1262 holding.
  • Financial Consulate first reported a position in Avanos Medical in Q3 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.